Cancer drugs are getting more effective at killing tumors, but there’s one big problem: many work like a shotgun blast and harm healthy cells as well. Researchers from Georgia Tech have now developed a new way to deliver drugs only to where they need to be, using nanoscale “glass” bottles.
Continue Reading
A clinical trial taking place in the Democratic Republic of the Congo has been terminated early due to the success of two drugs being investigated to treat the Ebola virus. The two drugs have displayed incredible survival rates, especially if given at the earliest stages of infection.
Continue Reading
Pancreatic cancer is one of the most deadly forms of the disease, thanks largely to the fact that the tumors tend to be much more solid. But now researchers have identified a promising new drug candidate that could linger for longer to worm its way in, and works when paired with other cancer drugs.
Continue Reading
Researchers at EPFL have developed a new biodegradable circuit that can be implanted to deliver painkillers in the body on demand. When the device is heated up from a source outside the body, it releases a controlled dose of a drug, before safely dissolving away when it’s no longer needed.
Continue Reading
Antibiotics aren’t picky, blasting good and bad bacteria alike and messing up the delicate balance of the gut microbiome. But now researchers have developed a more targeted approach, with drugs that are able to zero in on specific species of bacteria.
Continue Reading
When someone overdoses on opioid drugs, which is happening increasingly often, an injection of naloxone could save their life … if it's administered soon enough. A wearable system that's currently in development is intended to make that happen automatically.
Continue Reading
A novel experimental drug is showing promising results from its final phase of human clinical trials. Part of a new class of drugs called JAK-inhibitors, this therapy targets rheumatoid arthritis sufferers and is hoped to be approved for use by the FDA within the next 12 months.
Continue Reading
The FDA has granted accelerated approval to a new cancer drug called selinexor. This pill has been found to be successful in treating multiple myeloma in patients that hadn’t had success with other treatments. But at this very early stage the drug comes with some major caveats.
Continue Reading
A new drug delivery system has been developed that hides chemotherapy molecules inside fat cells that are quickly eaten up by hungry tumors. The method has been shown to be effective at targeting bone, colon and pancreatic cancers in animals, and human trials are proposed for the near future.
Continue Reading
Researchers have created a portable device they say can determine the efficacy of patient-specific cancer drugs with an accuracy of almost 96 percent. Teaming sensors with machine learning, the device provides rapid results, aiding the selection of better drugs while reducing potential side effects.
Continue Reading
See the stories that matter in your inbox every morning